|
DPP8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.65980001859612E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.18699999998684E-07 |
| Normal-vs-Stage2 |
1.078440E-03 |
| Normal-vs-Stage3 |
2.82319999600489E-08 |
| Normal-vs-Stage4 |
3.91840004887456E-09 |
| Stage1-vs-Stage2 |
5.642400E-01 |
| Stage1-vs-Stage3 |
1.734800E-01 |
| Stage1-vs-Stage4 |
1.255910E-02 |
| Stage2-vs-Stage3 |
1.515990E-01 |
| Stage2-vs-Stage4 |
3.083700E-02 |
| Stage3-vs-Stage4 |
3.083200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85800000332515E-08 |
| Normal-vs-AfricanAmerican |
3.302700E-03 |
| Normal-vs-Asian |
1.84959999982581E-07 |
| Caucasian-vs-AfricanAmerican |
5.709400E-01 |
| Caucasian-vs-Asian |
1.480970E-01 |
| AfricanAmerican-vs-Asian |
1.230820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.60409973771448E-10 |
| Normal-vs-Female |
8.45009999750346E-08 |
| Male-vs-Female |
9.153600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.13760000000729E-06 |
| Normal-vs-Age(41-60Yrs) |
7.0305999910758E-09 |
| Normal-vs-Age(61-80Yrs) |
3.6909000000751E-07 |
| Normal-vs-Age(81-100Yrs) |
2.055900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.855970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.319600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.737200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.350600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.962200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.956800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.424100E-02 |
| Classical-VS-Follicular |
4.221000E-01 |
| Classical-VS-Other |
8.475700E-02 |
| Classical-VS-Normal |
2.55390000036826E-07 |
| Tall-VS-Follicular |
1.787600E-01 |
| Tall-VS-Other |
3.273800E-01 |
| Tall-VS-Normal |
1.16119999948872E-07 |
| Follicular-VS-Other |
1.835170E-01 |
| Follicular-VS-Normal |
3.31090000005307E-06 |
| Other-VS-Normal |
6.601800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.05350000232119E-08 |
| Normal-vs-N1 |
1.84680000003823E-06 |
| N0-vs-N1 |
4.866800E-01 |
|
|
